TRexBio · 1 day ago
Senior Director, Regulatory Affairs
TRexBio is a clinical stage biotechnology company focused on developing revolutionary therapeutics for inflammatory diseases. The Senior Director, Regulatory Affairs will lead the regulatory strategy for the company's pipeline, working closely with clinical teams and engaging with regulatory authorities to ensure successful execution of regulatory deliverables.
BioinformaticsBiopharmaBiotechnology
Responsibilities
Serve as a key member of cross functional clinical and pre-clinical teams to develop and implement the US and global regulatory strategy across products
Lead Regulatory deliverables including INDs, CTAs, and other submissions
Oversee development of regulatory policies and procedures and SOPs
Engage with regulatory authorities as appropriate for product development
Monitor the competitive environment to sustain expertise in therapeutic area treatment management and new therapies, competitive products and features
Qualification
Required
Advanced degree (Master's or PhD) in Life Science with experience working as a regulatory project lead for INDs, CTAs, and BLAs
Minimum 10 years of documented professional experience in Regulatory Affairs, including in leadership positions within the biopharmaceutical industry with focus on biologics
Strong understanding of clinical development and how to present clinical data to FDA as well a proven track record in developing regulatory affairs strategies
Extensive regulatory experience including IND/CTA, NDA/BLA/MAA, lifecycle management, labelling, and developing regulatory strategies
Proven ability to collaborate effectively with multiple functional leaders, including Research, Development, Clinical, product Strategy, Manufacturing, and Quality across locations and cultures
Ability to travel domestically and internationally
Broad experience in Regulatory Affairs, working directly with FDA and international agencies
Experience with immunology and development of medicines for immune mediated diseases, biologics, CMC, Toxicology, Orphan Drugs development, breakthrough and fast track regulatory processes
Strong leadership experience, including mentoring staff and managing regulatory teams across locations
Excellent writing, communication, and presentation skills
Benefits
Discretionary Bonus
Company
TRexBio
TRexBio is a clinical-stage biotechnology company discovering and developing immunoregulatory medicines based on tissue Treg biology by leveraging cutting-edge computational biology tools, a focus on human tissue, and deep immunobiology expertise.
Funding
Current Stage
Growth StageTotal Funding
$169MKey Investors
Delos CapitalPolaris Partners
2024-11-13Series B· $84M
2022-03-08Series A· $26M
2021-06-22Series A· $59M
Recent News
2025-09-04
Google Patent
2025-02-08
TRex Bio | Mapping a New Frontier in Immunobiology
2025-01-10
Company data provided by crunchbase